Discovery of small molecule inhibitors of ubiquitin-like poxvirus proteinase I7L using homology modeling and covalent docking approaches

Essential for viral replication and highly conserved among poxviridae, the vaccinia virus I7L ubiquitin-like proteinase (ULP) is an attractive target for development of smallpox antiviral drugs. At the same time, the I7L proteinase exemplifies several interesting challenges from the rational drug design perspective. In the absence of a published I7L X-ray structure, we have built a detailed 3D model of the I7L ligand binding site (S2–S2′ pocket) based on exceptionally high structural conservation of this site in proteases of the ULP family. The accuracy and limitations of this model were assessed through comparative analysis of available X-ray structures of ULPs, as well as energy based conformational modeling. The 3D model of the I7L ligand binding site was used to perform covalent docking and VLS of a comprehensive library of about 230,000 available ketone and aldehyde compounds. Out of 456 predicted ligands, 97 inhibitors of I7L proteinase activity were confirmed in biochemical assays (∼20% overall hit rate). These experimental results both validate our I7L ligand binding model and provide initial leads for rational optimization of poxvirus I7L proteinase inhibitors. Thus, fragments predicted to bind in the prime portion of the active site can be combined with fragments on non-prime side to yield compounds with improved activity and specificity.

[1]  D. Fairlie,et al.  Protease inhibitors in the clinic. , 2005, Medicinal chemistry (Shariqah (United Arab Emirates)).

[2]  G. Andrés,et al.  African Swine Fever Virus Protease, a New Viral Member of the SUMO-1-specific Protease Family* , 2001, The Journal of Biological Chemistry.

[3]  R Abagyan,et al.  Homology modeling by the ICM method , 1995, Proteins.

[4]  R. Abagyan,et al.  Do aligned sequences share the same fold? , 1997, Journal of molecular biology.

[5]  Dennis E. Hruby,et al.  The Vaccinia Virus I7L Gene Product Is The Core Protein Proteinase , 2002, Journal of Virology.

[6]  Dennis E. Hruby,et al.  Molecular Dissection of the Vaccinia Virus I7L Core Protein Proteinase , 2003, Journal of Virology.

[7]  Jin Li,et al.  On Evaluating Molecular-Docking Methods for Pose Prediction and Enrichment Factors , 2006, J. Chem. Inf. Model..

[8]  Khashayar Karimian,et al.  Thiol proteases: inhibitors and potential therapeutic targets. , 2006, Current medicinal chemistry.

[9]  R. Quatrano.  Genomics , 1998, Plant Cell.

[10]  Guang-Wu Chen,et al.  Antiviral drug discovery targeting to viral proteases. , 2006, Current pharmaceutical design.

[11]  Chelsea M. Byrd,et al.  Development of an in vitro cleavage assay system to examine vaccinia virus I7L cysteine proteinase activity , 2005, Virology Journal.

[12]  Robert B. Raffa,et al.  DRUG-RECEPTOR THERMODYNAMICS : introduction and applications , 2001 .

[13]  M. Hochstrasser,et al.  A new protease required for cell-cycle progression in yeast , 1999, Nature.

[14]  C. Lima,et al.  Ulp1-SUMO crystal structure and genetic analysis reveal conserved interactions and a regulatory element essential for cell growth in yeast. , 2000, Molecular cell.

[15]  Ruben Abagyan,et al.  Estimating Local Backbone Structural Deviation in Homology Models , 2000, Comput. Chem..

[16]  David Reverter,et al.  A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex. , 2004, Structure.

[17]  Dennis E. Hruby,et al.  New Class of Orthopoxvirus Antiviral Drugs That Block Viral Maturation , 2004, Journal of Virology.

[18]  Wim J. N. Meester,et al.  Small‐Molecule Inhibitors and Probes for Ubiquitin‐ and Ubiquitin‐Like‐Specific Proteases , 2005, Chembiochem : a European journal of chemical biology.

[19]  Mika K Lindvall,et al.  Molecular modeling in cysteine protease inhibitor design. , 2002, Current pharmaceutical design.

[20]  K Tanaka,et al.  Identification and chromosomal assignment of USP1, a novel gene encoding a human ubiquitin-specific protease. , 1998, Genomics.

[21]  R. Rosenfeld.  Nature , 2009, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[22]  R Abagyan,et al.  Homology modeling with internal coordinate mechanics: Deformation zone mapping and improvements of models via conformational search , 1997, Proteins.

[23]  B. Moss,et al.  Role of the I7 Protein in Proteolytic Processing of Vaccinia Virus Membrane and Core Components , 2004, Journal of Virology.

[24]  Chelsea M. Byrd,et al.  A conditional-lethal vaccinia virus mutant demonstrates that the I7L gene product is required for virion morphogenesis , 2005, Virology Journal.

[25]  W Patrick Walters,et al.  A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance , 2004, Proteins.

[26]  Khashayar Karimian,et al.  Thiol-dependent enzymes and their inhibitors: a review. , 2002, Current medicinal chemistry.

[27]  Gerhard Klebe,et al.  Recent developments in structure-based drug design , 2000, Journal of Molecular Medicine.

[28]  S. Shuman,et al.  Vaccinia virus morphogenesis is blocked by a temperature-sensitive mutation in the I7 gene that encodes a virion component , 1993, Journal of virology.

[29]  Ruben Abagyan,et al.  ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformation , 1994, J. Comput. Chem..

[30]  F Gago.  Targeting HIV protease: from peptidomimetics to non-peptide inhibitors. , 1999, IDrugs : the investigational drugs journal.

[31]  R. M. Sweet,et al.  Crystal structure of the human adenovirus proteinase with its 11 amino acid cofactor. , 1996 .

[32]  John A Thomson,et al.  Hepatitis C virus NS3-4A protease inhibitors: countering viral subversion in vitro and showing promise in the clinic. , 2006, Current opinion in drug discovery & development.

[33]  Keith D Wilkinson,et al.  Structure of a complex between Nedd8 and the Ulp/Senp protease family member Den1. , 2005, Journal of molecular biology.

[34]  Ruben Abagyan,et al.  Comparative study of several algorithms for flexible ligand docking , 2003, J. Comput. Aided Mol. Des..

[35]  R Abagyan,et al.  Flexible protein–ligand docking by global energy optimization in internal coordinates , 1997, Proteins.